For example, overexpression of GRB10 and TDRD9 may enhance cancer cell proliferation, while downregulation of BCL7A, GPR18, KLRG1, and THEM4 could contribute to reduced immune surveillance and tumor evasion. This evidence concerns the gene GPR18 and neoplasm.